Padeliporfin potassium by ImPact Biotech for Esophageal Cancer: Likelihood of Approval

Padeliporfin potassium is under clinical development by ImPact Biotech and currently in Phase I for Esophageal Cancer.

New technique enables laser light to penetrate deeper into living tissues

Metabolic imaging is a noninvasive method that enables clinicians and scientists to study living cells using laser light, which can help them assess disease progression

December 12, 2024

Research reveals new insights into the role of efferocytosis in pancreatic cancer liver metastasis

A research paper published today (14 February 2024) in Nature Cancer details new insights into the role of efferocytosis – the burying of dead cells

February 14, 2024

Virtual physical therapy startup Hinge Health files to go public

Virtual physical therapy startup Hinge Health on Monday filed to go public, snapping a dry spell of digital health IPOs. Hinge treats musculoskeletal injuries and

March 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.